Issue 45 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

24

No.

45

November 27, 1998Nov 27, 1998

Free

DOWNLOAD THE PDF

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

In Brief: McDonald, Coolidge Lead ACS; Medals Awarded To Rosenberg, Boutwell, LeMaistre

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training

Recent Issues

Volume 52 | Issue 17 - May 01, 2026

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026